Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,401-1,425 of 2,022
RecruitingNCT06872463

Karolinska Schizophrenia Project

This study exists to learn from real-world information that can show how blood tests and biological markers fits into care. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Sweden
Sponsor
Karolinska Institutet
Condition
Schizophrenia
Not Yet RecruitingNCT06872424

The Effect of Psychosocial Skills Focused Group Psychoeducation in Schizophrenia Patients

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand what helps psychoeducation, a guided learning and support program, stay useful, realistic, and easier to follow over time.

SchizophreniaOtherOver 18 Weeks
Countries
Global
Sponsor
Gazi University
Condition
Schizophrenia
CompletedNCT02085421

Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
WithdrawnNCT03973853

How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT03140475

Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Versailles Hospital
Condition
Schizophrenia
TerminatedNCT02746510

Validation of a Clinical Screening Grid for Syndromic Schizophrenia

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherOver 15 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT03076346

Neural Biomarkers of Clozapine Response

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Schizophrenia
CompletedNCT03427580

Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT)

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Israel
Sponsor
Bar-Ilan University, Israel
Condition
Schizophrenia
CompletedNCT05623228

The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training.

This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 19 Years to 60 Years
Countries
Greece
Sponsor
Rakitzi, Stavroula
Condition
Schizophrenia
WithdrawnNCT05890768

Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of New Mexico
Condition
Schizophrenia
Not Yet RecruitingNCT06859112

The Effect of Logotherapy-Based Psychoeducation Applied to Family Members of Individuals Diagnosed with Schizophrenia on Finding Meaning, Hope and Depression

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand what psychoeducation, a guided learning and support program, could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
Global
Sponsor
aslı zeynep sipahi
Condition
Schizophrenia
CompletedNCT05953740

A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)

This study exists to better understand the safety of the medication MK-5720 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication MK-5720 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
CompletedNCT05032963

Neurocognition After Perturbed Sleep

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Schizophrenia
CompletedNCT01569659

High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
RecruitingNCT05036590

Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.

This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT05746494

The Efficacy of Neural Stimulation in Individuals With Schizophrenia

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
The University of Texas at Dallas
Condition
Schizophrenia
RecruitingNCT06839950

Sensory Profile and Early Clinical Signs of Calm Room Users

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Centre Hospitalier Esquirol
Condition
Schizophrenia
Active Not RecruitingNCT06838104

Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Pakistan
Sponsor
Lahore General Hospital
Condition
Schizophrenia
RecruitingNCT05763966

Uppsala Psychosis Cohort

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
Sweden
Sponsor
Uppsala University
Condition
Schizophrenia
RecruitingNCT04959201

Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
RecruitingNCT06021197

NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
RecruitingNCT04917302

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
RecruitingNCT06802939

RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 13 Years to 55 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia